ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671119 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671119; 2) Community: the network communities that were significantly associated with the response to NSC 671119; 3) Molecule: the relationships between components within communities and NSC 671119; 4) MDR: the compounds that were significantly associated with the NSC 671119.

NSC Compound Enrichment Correlation
NSC 339137 PHYSALOLACTONE 0.0352383000003056 0.5754236
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0352383000003056 0.46426338
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0352383000003056 0.53540522
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0352383000003056 0.23046709
NSC 409749 Null 0.0352383000003056 0.2876103
NSC 42972 Null 0.0352383000003056 0.43628677
NSC 47468 Null 0.0352383000003056 0.46646486
NSC 606497 Camptothecin Derivative 0.0352383000003056 0.19715076
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0352383000003056 0.31006881
NSC 615534 Null 0.0352383000003056 -0.22966099
Total:106  Current:77    [First] [Prev] [Next] [Last]